| Viswanathan S Iyer, MD | |
|
205 Grandview Ave Ste 301, Camp Hill, PA 17011-1704 | |
| (717) 695-0394 | |
| (717) 695-0398 |
| Full Name | Viswanathan S Iyer |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 34 Years |
| Location | 205 Grandview Ave Ste 301, Camp Hill, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871718338 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wooten Dialysis, Llc | Carlisle, PA | Dialysis facility |
| Davita West Shore | Lemoyne, PA | Dialysis facility |
| Fresenius Medical Care Camp Hill | Camp hill, PA | Dialysis facility |
| Dialysis Care Center Mechanicsburg, Llc | Mechanicsburg, PA | Dialysis facility |
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Carlisle Regional Medical Center | Carlisle, PA | Hospital |
| Holy Spirit Hospital | Camp hill, PA | Hospital |
| Fulton County Medical Center | Mcconnellsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Critical Care Medical Management Associates Pllc | 4880844521 | 21 |
| Pinnacle Health Medical Services | 7618960493 | 942 |
| Associates In Kidney Diseases Hypertension And Intensive Care Medicine | 8921162769 | 3 |
News Archive
For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.
Chronic diseases linked to obesity could put the brakes on economic progress in many developing countries unless urgent action is taken, experts warned at the opening of the first major international conference on obesity in Africa yesterday (Oct 28).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
A new large study from University College London researchers has shown that people who use E-cigarettes to aid them in quitting traditional cigarette smoking are 95 percent more likely to succeed when compared to those who are not using any "stop-smoking aids".
Findings reported in this week's New England Journal of Medicine (November 3 issue) highlight promising findings from two Seattle-based researchers on the origins of bacterial vaginosis (BV).
› Verified 1 days ago
| Entity Name | Spirit Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093013328 PECOS PAC ID: 8022922202 Enrollment ID: O20040402000053 |
News Archive
For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.
Chronic diseases linked to obesity could put the brakes on economic progress in many developing countries unless urgent action is taken, experts warned at the opening of the first major international conference on obesity in Africa yesterday (Oct 28).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
A new large study from University College London researchers has shown that people who use E-cigarettes to aid them in quitting traditional cigarette smoking are 95 percent more likely to succeed when compared to those who are not using any "stop-smoking aids".
Findings reported in this week's New England Journal of Medicine (November 3 issue) highlight promising findings from two Seattle-based researchers on the origins of bacterial vaginosis (BV).
› Verified 1 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.
Chronic diseases linked to obesity could put the brakes on economic progress in many developing countries unless urgent action is taken, experts warned at the opening of the first major international conference on obesity in Africa yesterday (Oct 28).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
A new large study from University College London researchers has shown that people who use E-cigarettes to aid them in quitting traditional cigarette smoking are 95 percent more likely to succeed when compared to those who are not using any "stop-smoking aids".
Findings reported in this week's New England Journal of Medicine (November 3 issue) highlight promising findings from two Seattle-based researchers on the origins of bacterial vaginosis (BV).
› Verified 1 days ago
| Entity Name | Associates In Kidney Diseases Hypertension And Intensive Care Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275784498 PECOS PAC ID: 8921162769 Enrollment ID: O20090123000036 |
News Archive
For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.
Chronic diseases linked to obesity could put the brakes on economic progress in many developing countries unless urgent action is taken, experts warned at the opening of the first major international conference on obesity in Africa yesterday (Oct 28).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
A new large study from University College London researchers has shown that people who use E-cigarettes to aid them in quitting traditional cigarette smoking are 95 percent more likely to succeed when compared to those who are not using any "stop-smoking aids".
Findings reported in this week's New England Journal of Medicine (November 3 issue) highlight promising findings from two Seattle-based researchers on the origins of bacterial vaginosis (BV).
› Verified 1 days ago
| Entity Name | Critical Care Medical Management Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194090878 PECOS PAC ID: 4880844521 Enrollment ID: O20221117000345 |
News Archive
For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.
Chronic diseases linked to obesity could put the brakes on economic progress in many developing countries unless urgent action is taken, experts warned at the opening of the first major international conference on obesity in Africa yesterday (Oct 28).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
A new large study from University College London researchers has shown that people who use E-cigarettes to aid them in quitting traditional cigarette smoking are 95 percent more likely to succeed when compared to those who are not using any "stop-smoking aids".
Findings reported in this week's New England Journal of Medicine (November 3 issue) highlight promising findings from two Seattle-based researchers on the origins of bacterial vaginosis (BV).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Viswanathan S Iyer, MD Po Box 3877, Joliet, IL 60434-3877 Ph: (815) 714-7149 | Viswanathan S Iyer, MD 205 Grandview Ave Ste 301, Camp Hill, PA 17011-1704 Ph: (717) 695-0394 |
News Archive
For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second.
Chronic diseases linked to obesity could put the brakes on economic progress in many developing countries unless urgent action is taken, experts warned at the opening of the first major international conference on obesity in Africa yesterday (Oct 28).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
A new large study from University College London researchers has shown that people who use E-cigarettes to aid them in quitting traditional cigarette smoking are 95 percent more likely to succeed when compared to those who are not using any "stop-smoking aids".
Findings reported in this week's New England Journal of Medicine (November 3 issue) highlight promising findings from two Seattle-based researchers on the origins of bacterial vaginosis (BV).
› Verified 1 days ago
Dr. Krishna Reddy Dondeti, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-972-4448 Fax: 717-972-7366 | |
Mohammad Shahriar Hussain Rumi, MBBS Nephrology Medicare: Accepting Medicare Assignments Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-972-4448 Fax: 717-972-7366 | |
George Ezeji, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 205 Grandview Ave Ste 301, Camp Hill, PA 17011 Phone: 717-695-0394 Fax: 717-695-0398 | |
Dr. Amit Kumar Misra, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 503 N 21st St, Camp Hill, PA 17011 Phone: 717-972-4448 Fax: 717-972-7366 | |
Maurice J. Lewis, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 890 Poplar Church Rd, Suite 508, Camp Hill, PA 17011 Phone: 717-761-3875 Fax: 717-761-7893 | |
Dr. Robert Denes Kusztos, MD Nephrology Medicare: Medicare Enrolled Practice Location: 4400 Carlisle Pike, Camp Hill, PA 17011 Phone: 717-975-9800 Fax: 717-975-5509 | |
Dr. Chandrasekhar Reddy Dinasarapu, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 503 N. 21st Street, Camp Hill, PA 17011 Phone: 717-972-4448 Fax: 717-972-7366 |